DI PAOLO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 4.260
EU - Europa 335
AS - Asia 108
OC - Oceania 1
Totale 4.704
Nazione #
US - Stati Uniti d'America 4.258
IT - Italia 93
CN - Cina 72
UA - Ucraina 61
IE - Irlanda 44
DE - Germania 43
SE - Svezia 19
GB - Regno Unito 17
SG - Singapore 17
FI - Finlandia 14
FR - Francia 13
KR - Corea 12
RU - Federazione Russa 10
PL - Polonia 9
BE - Belgio 5
CH - Svizzera 2
IN - India 2
LU - Lussemburgo 2
AU - Australia 1
CA - Canada 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GR - Grecia 1
HK - Hong Kong 1
JP - Giappone 1
KG - Kirghizistan 1
SI - Slovenia 1
TH - Thailandia 1
TR - Turchia 1
Totale 4.704
Città #
Woodbridge 1.362
Wilmington 1.080
Houston 1.023
Fairfield 153
Chandler 111
Ashburn 81
Seattle 58
Ann Arbor 53
Jacksonville 53
Cambridge 47
Dublin 44
Zhengzhou 32
Medford 29
Rome 29
Beijing 18
Dearborn 16
Lawrence 14
New York 14
Palo Alto 12
Singapore 10
Kraków 9
Menlo Park 7
Milan 7
Hefei 6
Mülheim 6
San Diego 6
Brussels 5
Moscow 5
Cagliari 4
Los Angeles 4
Messina 4
Colorado Springs 3
Norwalk 3
Shanghai 3
Bagnoregio 2
Creede 2
Kunming 2
London 2
Moriago della Battaglia 2
Nutley 2
Philadelphia 2
Pomezia 2
Tower Hamlets 2
Uboldo 2
Zurich 2
Andover 1
Ardea 1
Athens 1
Boardman 1
Boston 1
Brescia 1
Brierley Hill 1
Brindisi 1
Busca 1
Canberra 1
Cassino 1
Cernobbio 1
Chengdu 1
Chieti 1
Dallas 1
Falls Church 1
Fuzhou 1
Guangzhou 1
Hebei 1
Helsinki 1
Indiana 1
Jinan 1
Katy 1
Ljubljana 1
Ma Liu Shui 1
Molfetta 1
Motala 1
Nanchang 1
New Bedfont 1
North Hollywood 1
Olomouc 1
Osnago 1
Paris 1
Porto San Giorgio 1
Redwood City 1
Roseau 1
San Francisco 1
San Mateo 1
Santa Clara 1
Serra 1
Toronto 1
University Park 1
Vicenza 1
Washington 1
Xian 1
Totale 4.378
Nome #
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 406
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 400
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 397
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 394
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 390
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C 375
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation 366
Liver transplantation for the treatment of nodular regenerative hyperplasia 366
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 362
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis 338
A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B 315
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation 302
Sofosbuvir induced leucocytoclasic vasculitis: a case report 196
Studio pilota prospettico per testare l’efficacia dell’immunoprofilassi attiva mediante schedula di vaccinazione rinforzata e a lungo termine con vaccino ricombinante S in combinazione con lamivudina ed immunoglobuline anti-HBs (HBIg) come strategia di prevenzione della ricorrenza di infezione da virus dell’epatite B in pazienti sottoposti a trapianto di fegato per malattia HBV correlata 115
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 18
Totale 4.740
Categoria #
all - tutte 8.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.175 0 102 96 142 105 131 117 119 114 95 66 88
2020/2021644 79 75 69 82 59 62 71 72 20 15 34 6
2021/2022151 10 14 2 10 9 19 7 3 9 21 7 40
2022/2023282 24 28 16 30 25 51 23 20 32 7 17 9
2023/202485 12 0 6 1 9 22 0 11 0 5 0 19
2024/20257 6 1 0 0 0 0 0 0 0 0 0 0
Totale 4.740